Salute e Benessere

Immunovia announces updated financial calendar

Immunovia is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer. Immunovia is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for patients with cancer. Our first product, IMMray™ PanCan-d is the only blood test currently available specifically for the early detection of pancreatic cancer. The test has unmatched clinical performance. Commercialization of...
PR Newswire
19/07/2023

Ipsen announces European Commission decision on palovarotene for the treatment…

European Commission determines not to grant marketing authorization approval for palovarotene for fibrodysplasia ossificans progressiva (FOP)Decision follows negative opinion by the Committee for Medicinal Products for Human Use, in MayNo currently approved options available in the E.U. for the treatment of FOP, an ultra-rare condition, that continuously and permanently causes abnormal bone formation, leading to progressive mobility loss and shortened life expectancy Ipsen to continue...
Nasdaq GlobeNewswire
19/07/2023

Sleep Apnea Devices Market Size To Reach USD 13,386.5 Million by 2030: P&S…

The therapeutic devices category holds the larger share, and it is predicted to grow at a CAGR of about 9% in the years to come. This is mainly credited to the escalating count of OSA cases across the globe. The therapeutic devices category holds the larger share, and it is predicted to grow at a CAGR of about 9% in the years to come. This is mainly credited to the escalating count of OSA cases across the globe. Moreover, the PAP devices sub-category accounted for an about 35% share of the...
PR Newswire
19/07/2023

Orion Corporation: Managers' transactions – Veli-Matti Mattila

ORION CORPORATIONMANAGERS' TRANSACTIONS19 JULY 2023 at 17.15 EEST Orion Corporation: Managers' transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the...
Nasdaq GlobeNewswire
19/07/2023

Behavioral Health Software Market To Reach USD 9,346 Million by 2030: P&S…

Software Sales Generate Higher Revenue Software Sales Generate Higher Revenue Get the sample pages of this report:https://www.psmarketresearch.com/market-analysis/behavioral-health-software-market/report-sample Subscription Model Is Preferred among End Users Clinical Functionality of Behavioral Health Software Is Prized North America Is Most-Profitable Region for Software Vendors Behavioral Health Software Market Report Coverage Browse detailed report on...
PR Newswire
19/07/2023

READY-IN-A-CLICK: THE FIRST EVER VIRTUAL MAKEUP ON MICROSOFT TEAMS

The Maybelline Beauty App in Microsoft Teams allows users to adjust their personal style quickly and easily from directly within a Teams meeting. The virtual makeup looks provide a low-barrier way to try out different styles with the goal of democratizing makeup and empowering people with self-confidence, especially at work. The Maybelline Beauty App in Microsoft Teams allows users to adjust their personal style quickly and easily from directly within a Teams meeting. The virtual makeup looks...
PR Newswire
19/07/2023

SIMPLE FINGER PRICK TEST EXEMPLIFIES ADVANCES IN ALZHEIMER'S DISEASE BLOOD TESTS

Advancements in technology and practice reported for the first time at AAIC 2023 demonstrate the simplicity, transportability and diagnostic value of blood-based biomarkers for Alzheimer's, including the future potential for at-home testing by a patient or a family member. Advancements in technology and practice reported for the first time at AAIC 2023 demonstrate the simplicity, transportability and diagnostic value of blood-based biomarkers for Alzheimer's, including the future potential…
PR Newswire
19/07/2023

Carebook's CoreHealth Expands Partnership with Belgium Based AG Health Partner…

AGHP will deliver its enhanced well-being solutions through its long-standing partner CoreHealth. CoreHealth has rapidly established itself as a leading provider of innovative technology solutions that seamlessly connect employees and member populations to their well-being programs. Employees gain access to personalized health information, educational materials, interactive tools, and engaging challenges that foster positive lifestyle changes. CoreHealth's market leading customization…
PR Newswire
19/07/2023

Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as…

NEW YORK and LONDON, July19, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences executive Wendy DiCicco as interim Chief Financial Officer (CFO). Ms. DiCicco has more than 25 years of experience in the life sciences industry, currently serving as an independent financial and board advisor to companies, often in...
Nasdaq GlobeNewswire
19/07/2023

GHA Accreditation Helps Position Dr. Sulaiman Al-Habib Hospital in Al Khobar as…

HMG Al Khobar has garnered a remarkable reputation within the distinguished medical group, as evidenced by its numerous international accreditations. The hospital has successfully earned HIMSS EMRAM Stage-7 Accreditation from the USA, World Health Organization (WHO) Patient Safety Friendly Hospital Assessment, American College of Radiology (ACR), College of American Pathologists (CAP), and Association for the Advancement of Blood & Biotherapies (AABB), in addition to the CBAHI. It is also…
PR Newswire
19/07/2023

SK-II INVITES YOU TO 'SK-II SECRET KEY HOUSE' TO CELEBRATE WORLD PITERA™ MONTH

For decades, SK-II iconic and exclusive skincare ingredient PITERA™ has transformed the skin of millions of women, including some of the world's most renowned ones. It has empowered women to choose their skin destinies. Yet, after many years, PITERA™ remains elusive to many. Until now. For decades, SK-II iconic and exclusive skincare ingredientPITERA™has transformed the skin of millions of women, including some of the world's most renowned ones. It has empowered women to choose their skin...
PR Newswire
19/07/2023

Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032…

Request Sample Report on Nanotechnology Drug Delivery Market Analysis 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/10824 Request Sample Report on Nanotechnology Drug Delivery Market Analysis 2032- Allied Market Research-https://www.alliedmarketresearch.com/request-sample/10824 Prime determinants of growth Rise in prevalence of chronic diseases and advancement in nanotechnology drive the growth of the global nanotechnology drug delivery...
PR Newswire
19/07/2023

Long Steel Products Industry Expects Investments Galore in Asia Pacific - Grand…

Order your copy of the Free Sample of "Long Steel Products Industry Data Book - Steel Rebar, Carbon Steel Pipe Fittings, Steel Pipes & Tubes and Steel Wire Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research Order your copy of the Free Sample of "Long Steel Products Industry Data Book - Steel Rebar, Carbon Steel Pipe Fittings, Steel Pipes & Tubes and Steel Wire Market Size, Share, Trends Analysis, And Segment…
PR Newswire
19/07/2023

Functional Cosmetics Market worth $4.6 billion by 2028 - Exclusive Report by…

Browse in-depth TOC on "Functional Cosmetics Market" Browse in-depth TOC on "Functional Cosmetics Market" 150 – Tables 49 – Figures 198 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208028292 Conditioning agents segment to account for larger share in functional cosmetics market, in 2022. The conditioning agents for skin can influence the homeostatic process of repair and growth by augmenting the skin's renewal mechanism...
PR Newswire
19/07/2023

BioWorld by Clarivate Recognized for Excellence in Publishing

Now in its 35th year, the 2023 APEX Awards for Publication Excellence recognizes the outstanding works of professional communicators who demonstrate excellence in graphic design, editorial content, and the ability to achieve overall communications excellence. The BioWorld suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. Recognition by The APEX Awards further demonstrates that the long tradition of award-winning…
PR Newswire
19/07/2023

First patient treated with imlifidase in an investigator-initiated Phase 2 study…

The study is a single center, single arm, phase 2 trial led by Dr. Adrian Schreiber and Dr. Philipp Enghard, at Charité Universitätsmedizin, Berlin, Germany. The primary objective of the study is to assess efficacy and safety of imlifidase together with standard of care in the treatment of patients with pulmonary hemorrhage due to severe ANCA-associated vasculitis. The study is a single center, single arm, phase 2 trial led by Dr.Adrian Schreiberand Dr.Philipp Enghard, at Charité...
PR Newswire
19/07/2023

Shaare Zedek Medical Center Joins the TriNetX Network to Increase Clinical Trial…

Shaare Zedek Medical Center has provided top-level medical care for the people of Jerusalem since 1902, responding to the needs of a diverse population treating patients of every race, religion, and nationality. With a constant commitment to providing patients with the most advanced and compassionate care, the 1,000-bed facility treats hundreds of thousands of patients per year in its 30 departments and 70 outpatient clinics. Shaare Zedek Medical Center has provided top-level medical care for...
PR Newswire
19/07/2023

SKF Half-year report 2023: Strong sales, profit, and cash flow

Strong results in the second quarter Strong results in the second quarter Net sales wereSEK 27.1 billion(23.7), which is a record high quarterly number. The organic sales growth came in at 8%, representing the ninth consecutive quarter with an organic growth rate above 5%. We saw strong demand inEuropeandAsiawith an organic growth of around 10%. Demand was particularly strong in several of our targeted high-growth segments, for example aerospace, electrical vehicles, and...
PR Newswire
19/07/2023

Nicox Provides Second Quarter 2023 Financial and Business Highlights

Press Release Nicox Provides Second Quarter 2023 Financial and Business Highlights Net revenue1 of €0.9 million for the second quarter of 2023Cash position of €19 .0million , with a 12-month cash runway , as of June 30, 2023NCX 470 Denali Phase 3 clinical trial ~55% randomized July 19, 2023 – release at 7:30 am CETSophia Antipolis, France Nicox SA(Euronext Paris: FR0013018124, ALCOX), an international ophthalmology...
Nasdaq GlobeNewswire
19/07/2023

Santhera Announces Closing of Exclusive North America License Agreement with…

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, July 19 , 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of the exclusive license agreement for vamorolone in North America (NA) with Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) , announced on June 20 , 2023 [1] . The proceeds from the agreement extend Santhera's cash reach into 2025 .Together with the expected incomefrom ongoing operations , it provides funding for...
Nasdaq GlobeNewswire
19/07/2023

Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination…

Envlomet SR Tab., is a combination of two drugs, enavogliflozin and metformin hydrochloride. It has been approved as an adjuvant for dietary and exercise therapies to improve blood glucose control in patients with type 2 diabetes. Metformin is used as first-line treatment for type 2 diabetes, and enavogliflozin effectively lowers blood glucose levels with just 0.3mg, a dosage that is only 1/30 of other drugs in the same class. Envlomet SR Tab., is a combination of two drugs, enavogliflozin…
PR Newswire
19/07/2023

AIM ImmunoTech Issues Notice that an Unaffiliated Third Party and Organization…

AIM ImmunoTech Inc. (NYSE American: AIM)(“AIM” or the “Company”) today issued a notice that the Company has learned that unknown person(s) and/or organization(s) are claiming to represent AIM ImmunoTech Europe and are using the Company's name without authorization. Specifically, there is aLinkedIn profilepromoting misinformation related to AIM's ongoing clinical activities, and the profile purports to be linked to the organization Clavinvest. The unauthorized and unaffiliated profile...
Nasdaq GlobeNewswire
19/07/2023

Inflammatory Myositis Market to Accelerate Substantially at a CAGR of 11.7% by…

Key Takeaways from the Inflammatory Myositis Market Report Key Takeaways from the Inflammatory Myositis Market Report Discover which therapies are expected to grab the major inflammatory myositis market share @Inflammatory Myositis Market Report Inflammatory Myositis Overview Inflammatory myositis, often known as myositis, is a rare autoimmune condition characterized by muscular inflammation. Polymyositis, dermatomyositis, inclusion body myositis, and necrotizing autoimmune...
PR Newswire
18/07/2023

First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in…

The clinical hypothesis is that the combination of TLX250 and a DNA-PK inhibitor provides an enhancement in potency through their synergistic action on cancer cells. Targeted radiation effectively induces DNA damage in targeted cancer cells and the DNA-PK inhibitor may act to prevent the cell from repairing this damage, resulting in higher potency at lower doses. This hypothesis was confirmed in preclinical studies, conducted under a strategic research collaboration between Merck and Telix…
PR Newswire
18/07/2023
Altri  Comunicati